Unibail-Rodamco-Westfield Sells The Village in San Fernando Valley
Paris, Amsterdam, December 27, 2022
Press release
Unibail-Rodamco-Westfield Sells The Village in San Fernando Valley
Transaction takes URW’s total US deleveraging proceeds to $1.1 Bn1
Unibail-Rodamco-Westfield (“URW”) today announced that it has completed the sale of The Village, an outdoor lifestyle destination in the San Fernando Valley of Los Angeles, to the Kroenke Organization. The sale price of $325 Mn (at 100%, URW share 55%), reflects an initial yield of 5.6% on the in-place Net Operating Income, and a 10.6% discount to the last unaffected appraisal.
The Village is an A+-rated, 600,000 square foot property located next to the Promenade development site, which URW recently sold for $150 Mn (at 100%, URW share 55%). URW’s flagship property in the area, Westfield Topanga, was not a part of the transaction.
With the sale of The Village, URW has made $1.1 Bn in total proceeds to date from the planned reduction of its financial exposure to the US, including the sales of Westfield Santa Anita for $537.5 Mn (URW share 49%), the Promenade development parcel for $150 Mn (URW share 55%), the Palisade residential building for $238 Mn (URW share 50%), and the ownership transfer of five other regional properties.
Fabrice Mouchel, Chief Financial Officer of URW, said: “This transaction is another step in the streamlining of our US regional asset portfolio as part of our wider plan to radically reduce our financial exposure to the US, and demonstrates the continued investor interest in high quality assets with strong operating performance.”
For more information, please contact:
Investor Relations
Audrey Arnoux
+33 6 61 27 07 39
audrey.arnoux@urw.com
Media Relations
UK/Global:
Cornelia Schnepf – Finelk
+44 7387 108 998
Cornelia.Schnepf@finelk.eu
United States:
Molly Morse – Kekst CNC
+ 1 212 521 4826
molly.morse@kekstcnc.com
France:
Nathalie Feld – Image7
+33 6 30 47 18 37
nfeld@image7.fr
About Unibail-Rodamco-Westfield
Unibail-Rodamco-Westfield is an owner, developer and operator of sustainable, high-quality real estate assets in the most dynamic cities in Europe and the United States.
The Group operates 80 shopping centres in 12 countries, including 45 which carry the iconic Westfield brand. These centres attract over 900 million visits annually and provide a unique platform for retailers and brands to connect with consumers. URW also has a portfolio of high-quality offices, 10 convention and exhibition venues in Paris, and a €3 Bn development pipeline of mainly mixed-use assets. Currently, its €55 Bn portfolio is 87% in retail, 6% in offices, 5% in convention and exhibition venues, and 2% in services (as at June 30, 2022).
URW is a committed partner to major cities on urban regeneration projects, through both mixed-use development and the retrofitting of buildings to industry-leading sustainability standards. These commitments are enhanced by the Group’s Better Places 2030 agenda, which strives to make a positive environmental, social and economic impact on the cities and communities where URW operates.
URW’s stapled shares are listed on Euronext Amsterdam and Euronext Paris (Ticker: URW), with a secondary listing in Australia through Chess Depositary Interests. The Group benefits from a BBB+ rating from Standard & Poor’s and from a Baa2 rating from Moody’s.
For more information, please visit www.urw.com
About the Kroenke Organization
The Kroenke Organization is owned by E. Stanley Kroenke, Owner/Chairman of the Super Bowl LVI Champion Los Angeles Rams and the developer of SoFi Stadium and Hollywood Park – a near 300-acre sports and entertainment destination in Inglewood, Calif.
Much of Kroenke's professional life has been dedicated to real estate development. In 1983, he founded the Kroenke Group, a leading national firm that builds and manages shopping centers and apartment buildings across the United States. The Kroenke Group owns and operates shopping centers in 39 states that amount to 40 million square feet. Throughout his career, he has launched and transformed dozens of business ventures, including television and radio stations, warehouses, and renowned vineyards and ranches in North America and Europe. In a confluence of his areas of expertise – sports, retail, commercial and residential development – Kroenke constructed SoFi Stadium and continues to develop Hollywood Park.
1 At URW Group share to date.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Bondholders approve amended terms of the 2024 convertible bonds6.5.2024 18:35:00 CEST | Press release
Ad hoc announcement pursuant to Art. 53 LR Bondholders approve amended terms of the 2024 convertible bonds The proposed amendments to the terms of the 2024 convertible bond have been approved by the bondholders and will become binding and effective upon approval by the higher cantonal composition authority. Allschwil, Switzerland – May 6, 2024 Idorsia Ltd. (SIX: IDIA) today announced the positive outcome of a bondholder meeting held at 17:30 CEST on May 6, 2024. The bondholder meeting for holders of Idorsia’s outstanding 2024 convertible bonds (ISIN: CH0426820350) (the Bonds) was held to vote on amendments to the terms of the Bonds. 83.5% of the total outstanding bondholders voted in favor of the amendments proposed by Idorsia – significantly exceeding the required two thirds majority threshold. The approved Bond terms include an amended conversion price of CHF 6.00, extended maturity date of January 17, 2025, and the option to call the Bonds at par, in full or in part, at any time upo
Repurchase of Shares6.5.2024 18:30:00 CEST | Press release
Repurchase of Shares Amsterdam, the Netherlands - Flow Traders Ltd. (Euronext: FLOW) has repurchased 46,070 of its own shares in the period from 29 April 2024 up to and including 3 May 2024 at an average price of €19.57. This is in accordance with the €15 million share buyback extension program originally announced on 27 October 2022, of which the period of execution was announced on 28 July 2023 to be extended by 12 months to 26 October 2024. The consideration of this purchase was €0.9 million. The total number of shares purchased under this program to date is 516,082 shares at an average price of €17.30 for a total consideration of €8.9 million. 2,278,464 shares were held in treasury as of 6 May 2024. Contact Details Flow Traders Ltd. Investors Eric Pan Phone: +31 20 7996180 Email: investor.relations@flowtraders.com About Flow Traders Flow Traders is a leading trading firm providing liquidity in multiple asset classes, covering all major exchanges. Founded in 2004, Flow Traders is a
Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD6.5.2024 18:00:00 CEST | Press release
` Important Advances in Oxurion's R&D Program on Geographic Atrophy secondary to AMD Leuven, BELGIUM – May 6, 2024 – 6:00 PM CET, Oxurion NV (Euronext Brussels: OXUR), an innovative biopharmaceutical company based in Leuven, today announces important progress in its preclinical program targeting Geographic Atrophy (GA), a severe and underserved form of Age-Related Macular Degeneration (AMD). This recently launched program has reached the first step with the identification of 50 targets that have the potential to provide better treatment options for GA. These targets are derived from a cutting-edge CRISPR-based target discovery platform, which consists in a genome-wide screening in a phenotypic cellular assay reflective of GA disease. The preclinical team successfully already confirmed the potential of several of these targets across various relevant in vitro models. Next step is to continue the in vitro validation of the remaining identified targets and start their evaluation in GA ani
Appointment of Mary Ann Packo as CEO of Ipsos in North America6.5.2024 17:45:00 CEST | Press release
Appointment of Mary Ann Packo as CEO of Ipsos in North America Paris, New York - May 6, 2024 - Ipsos, one of the world's leading market research companies, is pleased to announce the appointment of Mary Ann Packo, effective today, as CEO of Ipsos in North America. Reporting to Ben Page, CEO of Ipsos, she joins the Group Management Committee. Mary Ann Packo has been working in the market research industry for over 25 years. She has extensive international experience, particularly in the field of brand building, marketing, advertising, consumer research, digital measurement and advisory services. Prior to joining Ipsos, Mary Ann was a Senior Partner at Hypothesis Group, a premium insights, strategy, and design agency. She began her career in the United States, before moving to Paris in 1995 as Executive Director of a joint venture dedicated to studies for Consumer Goods companies, and whose two shareholders were NFO, one of the leading American marketing research companies, and Ipsos. Ba
Coface records a very good start to the year with a net income of €68.4m, up 11.9%6.5.2024 17:36:00 CEST | Press release
Coface records a very good start to the year with a net income of €68.4m, up 11.9% Paris, 6 May 2024 – 17.35 Turnover: €464m, down -1.6% at constant FX and perimeterTrade credit insurance premiums decreased by -3.3%; growth in client activities was nil at the start of the year, after a negative H2-23Client retention still high (93.8%) but down from records; pricing effect remained negative (-1.3%)Double-digit growth in business information (+21.6% at constant FX) and debt collection (+24.1%); factoring down by -6.3%Net loss ratio at 35.8%, improved by 4.9 ppts; net combined ratio at 63.1%, improved by 3.2 pptsGross loss ratio at 33.2%, improved by 7.5 ppts with stable opening year reserving and high reserve releasesNet cost ratio up by 1.6 ppt to 27.3%, reflecting lower revenues and continued investments partially offset by better product mixNet income (group share) at €68.4m, up +11.9% compared to Q1-23Annualised RoATE1 at 14.8% Unless otherwise indicated, change comparisons refer to